Ask Nigeria Header Logo

Health insurers worry on rising drug prices

Photo of author

By Abdulwasiu Usman

Expenses associated with importing pharmaceutical products have soared.

Nigerian Health insurance companies are encountering mounting challenges on their profit margins due to a recent surge in drug prices. This year has witnessed an alarming increase of over 200 percent in the cost of certain medications, impacting the contractual agreements between Health Management Organisations (HMO) and their network of providers including hospitals and pharmacies. Several providers are demanding a review of rates, further exacerbating the strain on insurers. Tope Adeniyi, the CEO of AXA Mansard Health said HMOs partner with healthcare providers to deliver healthcare services to their enrolled clients.

The rise in drug prices is primarily a result of the persisting decline of the naira in light of a shortage of foreign exchange. Consequently, the expenses associated with importing products and essential materials have soared, thus significantly driving up costs. Gideon Anumba, a doctor and head of operations at Leadway Health Limited, expressed that healthcare providers have been frequently approaching them to discuss revising the previously agreed rate. This increase in requests, now coming in quarterly, is primarily due to the substantial escalation in the expenses associated with drugs and various tools in hospitals.

Rising drug costs exert tremendous strain on HMOs.

Anumba said considering that their policies are annual, the premiums are fixed for the entire year and cannot be altered at any moment, similar to the approach followed by healthcare providers. In the case of policy renewals as well, price sensitivity in the market makes it difficult to implement the necessary premium hikes to cover the rising healthcare expenses. As a result, our profit margins have been significantly impacted, putting certain policies at a loss, he explained. He stated that the healthcare industry in Nigeria heavily relies on imports, making the high exchange rate the primary factor driving up costs.

He added that the sole prospect lies in the economic upturn and the stabilization of the naira-to-US dollar exchange rate. Harrison Okafor, a doctor and director of medical services at MetroHealth HMO, stated that the rising cost of medications exert tremendous strain on HMOs. He said due to the soaring expenses of medications and other medical supplies, numerous health plans provided by HMOs were adversely affected, resulting in financial losses as HMOs had predetermined annual premiums with their clients.

Shortage of FX continues to affect the pharmaceutical chain.

Sam Ohuabunwa, former president of the Pharmaceutical Society of Nigeria, said for years now, the shortage of foreign exchange has been a persistent challenge for the pharmaceutical chain of the health industry. This has significantly hampered the importation of various essential products, particularly crucial raw materials. He remarked that the decrease in imports is not due to the amplification of local manufacturing influence but instead due to the insufficient dollar supply by the Central Bank of Nigeria, compelling manufacturers to rely on the black market for a substantial portion of their foreign exchange requirements.

According to a report by the National Centre for Biotechnology Information (NCBI), Nigeria relies on foreign countries for the provision of active pharmaceutical ingredients and excipients, despite having over 115 registered pharmaceutical manufacturers in the country. It highlighted the lack of emphasis on local production of raw materials, pharmaceutical dosage formulations, and processing equipment, which has led to a decrease in the country’s pharmaceutical manufacturing capability. Emphasizing the significant role of the pharmaceutical industry, it pointed out that it is crucial to carefully address developmental concerns that impact this sector.

Government urged to engage with prominent companies.

Pamela Ajayi, president of the Healthcare Federation of Nigeria, voiced a pressing demand for the elimination of all import-related taxes and duties by the federal government, thereby facilitating equipment importation to bolster local drug production. Drawing attention to the significance of collaboration, Ajayi urged the government to engage with prominent pharmaceutical companies like Emzor and Fidson to drive positive change in the sector. Local production in Nigeria faces obstacles like inadequate infrastructure and unreliable power supply. Given that almost all drugs consumed in the country are imported, it is imperative to support manufacturers in order to boost their production capacity.

Related Link

Wikipedia: Website

The content on is given for general information only and does not constitute a professional opinion, and users should seek their own legal/professional advice. There is data available online that lists details, facts and further information not listed in this post, please complete your own investigation into these matters and reach your own conclusion. accepts no responsibility for losses from any person acting or refraining from acting as a result of content contained in this website and/or other websites which may be linked to this website.

Fact Checking Tool -

5 1 vote
Rate This Article
Newest Most Voted
Inline Feedbacks
View all comments
3 months ago

Health insurers worry on rising drug prices. – Expenses associated with importing pharmaceutical products have soared. – Express your point of view.

Adeoye Adegoke
3 months ago

Rising drug prices and the increasing expenses of importing pharmaceutical products are indeed concerning for health insurers. It puts a strain on the healthcare system and can potentially lead to higher premiums for policyholders. It’s important for stakeholders to work together to find solutions that balance affordability and access to necessary medications.

3 months ago

The escalating drug prices are deeply concerning, impacting both health insurers and citizens. The reliance on imports and challenges in local production highlight the need for urgent government intervention to address the shortage of foreign exchange and support the pharmaceutical industry. The call to eliminate import-related taxes and collaborate with key companies reflects a shared desire for sustainable solutions to ensure affordable and accessible healthcare.

3 months ago

Concerned about growing drug costs are health insurers. The costs incurred in importing pharmaceutical products have increased dramatically. This worries me a great deal. It is concerning how quickly the drug-processing industry has grown

3 months ago

Rising prescription costs are extremely alarming, affecting citizens and health insurers alike. Undoubtedly, the escalating expenses linked to importing pharmaceutical items and prescription drug charges are of concern to health insurance. Developing solutions that balance supply to necessary drugs with cheap price